Articles From: Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014 to Genocea Presents Phase 1 Immunology Data for Novel Pneumoccocus Vaccine at ICAAC


Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a conference call and live audio webcast on Wednesday, August 13, 2014 at 8:00 a.m. ET to report second quarter 2014 financial results and provide a corporate update.
Sign-up for Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014 investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced second quarter 2014 operating and financial results and reiterated 2014 guidance.
Sign-up for Epizyme Announces Second Quarter 2014 Financial Results and Provides Corporate Update investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, reported pre-clinical data and early clinical observations from an ongoing Phase 1 trial, being conducted in collaboration with Eisai, the Institut Gustave Roussy, and the Institut Bergonie, of EZH2 inhibitor EPZ-6438 (E7438) in patients with advanced solid tumors and B-cell lymphomas.
Sign-up for Epizyme Presents Pre-Clinical Data and Early Clinical Observations from Ongoing Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) at ASH Meeting on Lymphoma Biology investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that Jason Rhodes, President and Chief Financial Officer, has resigned from the company, effective September 30, 2014.
Sign-up for Epizyme Announces Resignation of President and Chief Financial Officer Jason Rhodes investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in five upcoming conferences in September: About Epizyme, Inc. Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers.
Sign-up for Epizyme to Present at Upcoming Conferences in September investment picks
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the appointments of Peter Ho, M.D., Ph.D., as Chief Development Officer and Michael Shih, J.D. as Vice President, Business Development.
Sign-up for Epizyme Appoints Peter Ho, M.D., Ph.D., as Chief Development Officer and Michael Shih, J.D., as Vice President, Business Development investment picks
- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time - ABSORB IV will compare Absorb to a best-in-class, metallic drug eluting stent in people with coronary artery disease, the most common type of heart disease - Trial will prospectively measure rates of angina, or chest pain, in the first randomized controlled heart stent trial with angina as a primary endpoint to assess impact of angina on healthcare costs and quality of life ABBOTT PARK, Ill., Sept.
Sign-up for Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device investment picks
2014/8/6
MADISON, N.J. , Aug.
Sign-up for CENTURY 21 Real Estate Sweeps J.D. Power 2014 Home Buyer/Seller Satisfaction Study investment picks
Korn Ferry (NYSE:KFY), a single source of leadership and talent consulting services, today announced the launch of Korn Ferry’s Four Dimensions of Leadership & Talent (KF4D). KF4D, which will serve as the firm’s new talent intelligence “engine,” helps companies to identify top talent for their organizations, assess performance and developmental gaps of their leaders, measure the effectiveness of their global talent workforce overall – and even compare their level of talent to their industry peers.
Sign-up for Korn Ferry Launches New Big Data Talent Analytics Engine to Help Organizations Select Top Leaders and Assess Overall Talent Performance investment picks
As oil and gas production continues to rise in the nation’s top shale formations, On the Move Systems Corp.
Sign-up for OMVS Examines New Revenue Potential in Oil & Gas Trucking investment picks
2014/7/15
Collection to Deliver the Ultimate Fashion for Every Girl in a Digitally Enhanced Experience NEW YORK , July 15, 2014 /PRNewswire/ -- Hearst Brand Development announced today the exclusive launch of Seventeen Magazine 's fashion collection at Sears .
Sign-up for Seventeen Magazine Fashion Collection To Launch Exclusively At Sears investment picks
http://media.marketwire.com/attachments/201111/41335_581026_MagnumLogo.jpg http://media.marketwire.com/attachments/201406/TN-76575_magnumhunter.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1125798&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for Magnum Hunter Resources Announces Joint Development Venture in Washington County, Ohio investment picks
Global cinema giant adopts Jive's enterprise communication and collaboration solutions to support staff in providing "luxury cinema" experience PALO ALTO, Calif.
Sign-up for Cinepolis Chooses Jive To Strengthen Collaborative Workstyle And Unify Company Culture Across 27,000 Employees investment picks
2014/6/27
Morgan Stanley today announced Healthy Newark , an innovative philanthropic program connecting several local nonprofits, schools and hospitals to deliver a linked package of the building blocks to a healthy childhood.
Sign-up for Morgan Stanley Healthy Cities Creates Linked Network of Children’s Wellness Programming in Newark investment picks
2014/9/12
By Frances Robinson And Laurence Norman BRUSSELS--The European Union extended its sanctions on Russia and rebels in eastern Ukraine on Friday, adding 15 companies and 24 individuals to its blacklist and imposing new measures against the country's oil and defense sectors, in an effort to target those dealing with the separatists.
Sign-up for EU Widens Sanctions on Russian Companies, Individuals Over Ukraine Crisis investment picks
Heatwurx®, Inc. (OTCQB:HUWX), a premier developer of patented eco-friendly asphalt restoration and permanent repair technology, has begun selling franchises of its service provider, Dr.
Sign-up for Heatwurx® Franchises Dr. Pave Worldwide, LLC’s Asphalt Repair and Restoration Service investment picks
BOSTON , July 1, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) ("PAREXEL" or the "Company"), a global clinical research organization , announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services ("ATLAS"), a provider of clinical research services in Turkey , the Middle East , and North Africa .
Sign-up for PAREXEL International Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey investment picks
2014/7/15
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0956916003&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.marketwire.com/library/20140714-956916aS.jpg Janet Peddigrew, Vice President & Managing Director, Ontario Region, BMO Harris Private Banking (C), presents a $1 million donation to former New York Rangers & Smilezone Foundation Co-founder Adam Graves (L), and Scott Bachly, Smilezone Co-founder (R). http://www.marketwire.com/library/20140714-956916bS.jpg Sportsnet Sportcaster Nick Kypreos; Janet Peddigrew, Vice President & Managing Director, Ontario Region, BMO Harris Private Banking; Hockey Night in Canada's Glenn Healy; Scott Bachly, Smilezone Co-founder; and former New York Rangers & Smilezone Foundation Co-founder Adam Graves at the second annual Celebrity Smilezone
Sign-up for BMO Announces $1 Million Donation to Smilezone Foundation to Improve Healthcare Facilities for Children investment picks
2014/7/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0956916001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.marketwire.com/library/20140714-956916aS.jpg Janet Peddigrew, Vice President & Managing Director, Ontario Region, BMO Harris Private Banking (C), presents a $1 million donation to former New York Rangers & Smilezone Foundation Co-founder Adam Graves (L), and Scott Bachly, Smilezone Co-founder (R). http://www.marketwire.com/library/20140714-956916bS.jpg Sportsnet Sportcaster Nick Kypreos; Janet Peddigrew, Vice President & Managing Director, Ontario Region, BMO Harris Private Banking; Hockey Night in Canada's Glenn Healy; Scott Bachly, Smilezone Co-founder; and former New York Rangers & Smilezone Foundation Co-founder Adam Graves at the second annual Celebrity Smilezone
Sign-up for BMO Announces $1 Million Donation to Smilezone Foundation to Improve Healthcare Facilities for Children investment picks
2014/6/18
Marsh, a global leader in insurance broking and risk management, today announced that it has reached a definitive agreement to acquire a majority stake in Semusa, a leading insurance broker and advisor in Panama and Marsh’s long-standing local correspondent broker.
Sign-up for Marsh to Acquire Majority Stake in Panama-Based Broker Semusa investment picks
The EnLink Midstream companies, EnLink Midstream Partners, LP (NYSE:ENLK) (the Partnership) and EnLink Midstream, LLC (NYSE:ENLC) (the General Partner), today announced plans to construct a new 45-mile, eight inch condensate pipeline and six natural gas compression and condensate stabilization facilities that will service major producer customers in the Utica Shale, including Eclipse Resources.
Sign-up for EnLink Midstream Announces New 45-Mile Condensate Pipeline in Ohio River Valley; Adds Compression and Stabilization Facilities investment picks
TOKYO, Aug.
Sign-up for UBIC Obtains Additional Patent for Predictive Coding investment picks
TOKYO, Aug.
Sign-up for UBIC Obtains Japanese Patent for Predictive Coding investment picks
http://media.marketwire.com/attachments/201212/109000_36797_HP_Blue_RGB_72_MD.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143062&ProfileId=051205&sourceType=1 WASHINGTON, DC --
Sign-up for HP Redefines Active Defense to Combat Cyberthreats at HP Protect 2014 investment picks
2014/9/4
By Gautham Nagesh and Rolfe Winkler Google Inc. has agreed to settle a Federal Trade Commission complaint that it allowed children to rack up millions of dollars in charges in its mobile app store without their parents' knowledge or consent.
Sign-up for Google Settles FTC Complaint Over Mobile App Purchases by Children -- 2nd Update investment picks
2014/9/4
By Gautham Nagesh and Rolfe Winkler Google Inc. has agreed to settle a Federal Trade Commission complaint that it allowed children to rack up millions of dollars in charges in its mobile app store without their parents' knowledge or consent.
Sign-up for Google Settles FTC Complaint Over Mobile App Purchases by Children -- Update investment picks
By Gautham Nagesh Dozens of Web companies and advocacy groups, including reddit, Netflix Inc. (NFLX) and Upworthy, are planning an online protest Wednesday to urge regulators to ban any fast lanes on the Internet.
Sign-up for Websites to protest net neutrality plan investment picks
2014/9/10
By Gautham Nagesh Wireless carriers could soon be subject to new rules on how they handle content on their networks, Federal Communications Chairman Tom Wheeler suggested in a speech to the industry on Tuesday.
Sign-up for FCC chairman: Broadband rules could cover wireless networks investment picks
Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today presented data from a Phase 1 study of GEN-004, an investigational vaccine designed to prevent disease caused by all serotypes of pneumococcus ( Streptococcus pneumoniae ) The poster (G-291), titled “Safety and Immunogenicity of a Novel Lipidated Protein Subunit Streptococcus Pneumoniae vaccine,” was presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC.
Sign-up for Genocea Presents Phase 1 Immunology Data for Novel Pneumoccocus Vaccine at ICAAC investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014 to Genocea Presents Phase 1 Immunology Data for Novel Pneumoccocus Vaccine at ICAAC
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices